{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:17:13Z","timestamp":1779247033674,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/BIM\/04293\/2019"],"award-info":[{"award-number":["UID\/BIM\/04293\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/140271\/2018"],"award-info":[{"award-number":["SFRH\/BD\/140271\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012637","name":"University of the East","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.actbio.2020.12.019","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T06:13:42Z","timestamp":1608099222000},"page":"316-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Development of pH-sensitive vaginal films based on methacrylate copolymers for topical HIV-1 pre-exposure prophylaxis"],"prefix":"10.1016","volume":"121","author":[{"given":"Fernando","family":"Notario-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1523-2619","authenticated-orcid":false,"given":"Joana","family":"Galante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Araceli","family":"Mart\u00edn-Illana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"Cazorla-Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ruiz-Caro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2317-2759","authenticated-orcid":false,"given":"Jos\u00e9","family":"das Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda-Dolores","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2020.12.019_bib0001","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2147\/DDDT.S133170","article-title":"Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes","volume":"11","author":"Notario-P\u00e9rez","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.actbio.2020.12.019_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147743","article-title":"Safety, acceptability and adherence of dapivirine vaginal ring in a microbicide clinical trial conducted in multiple countries in Sub-Saharan Africa","volume":"11","author":"Nel","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actbio.2020.12.019_bib0003","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"MTN-020\u2013ASPIRE study team, use of a vaginal ring containing dapivirine for HIV-1 prevention in women","volume":"375","author":"Baeten","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2020.12.019_bib0004","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","article-title":"Ring study team, safety and efficacy of a dapivirine vaginal ring for HIV prevention in women","volume":"375","author":"Nel","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2020.12.019_bib0005","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.3390\/md15020050","article-title":"Influence of chitosan swelling behaviour on controlled release of tenofovir from mucoadhesive vaginal systems for prevention of sexual transmission of HIV","volume":"15","author":"Notario-P\u00e9rez","year":"2017","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.actbio.2020.12.019_bib0006","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"CAPRISA 004 Trial Group, Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.actbio.2020.12.019_bib0007","doi-asserted-by":"crossref","unstructured":"K.H. Mayer, L.A. Maslankowski, F. Gai, W.M. El-Sadr, J. Justman, A. Kwiecien, B. M\u00e2sse, S.H. Eshleman, C. Hendrix, K. Morrow, J.F. Rooney, L. Soto-Torres; HPTN 050 Protocol Team, Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women, AIDS 20 (2006) 543\u2013551.","DOI":"10.1097\/01.aids.0000210608.70762.c3"},{"key":"10.1016\/j.actbio.2020.12.019_bib0008","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/infdis\/jiu026","article-title":"Sensitive tenofovir resistance screening of HIV-1 from the genital and blood compartments of women with breakthrough infections in the CAPRISA 004 tenofovir gel trial","volume":"209","author":"Wei","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actbio.2020.12.019_bib0009","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/QAI.0000000000001136","article-title":"First-in-human trial of MIV-150 and zinc acetate coformulated in a carrageenan gel: safety, pharmacokinetics, acceptability, adherence, and pharmacodynamics","volume":"73","author":"Friedland","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.actbio.2020.12.019_bib0010","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s11095-017-2224-1","article-title":"A dose ranging pharmacokinetic evaluation of IQP-0528 released from intravaginal rings in non-human primates","volume":"34","author":"Su","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2020.12.019_bib0011","doi-asserted-by":"crossref","first-page":"e25628","DOI":"10.1002\/jia2.25628","article-title":"Efficacy of silk fibroin biomaterial vehicle for in vivo mucosal delivery of Griffithsin and protection against HIV and SHIV infection ex vivo","volume":"23","author":"Crakes","year":"2020","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.actbio.2020.12.019_bib0012","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women","volume":"367","author":"Van Damme","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2020.12.019_bib0013","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2020.12.019_bib0014","series-title":"Drug Delivery and Development of Anti-HIV Microbicides","author":"das Neves","year":"2014"},{"key":"10.1016\/j.actbio.2020.12.019_bib0015","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S1473-3099(18)30428-6","article-title":"Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"18","author":"Delany-Moretlwe","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.actbio.2020.12.019_bib0016","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2009.12.042","article-title":"Freeze-dried, mucoadhesive system for vaginal delivery of the HIV microbicide, dapivirine: optimisation by an artificial neural network","volume":"388","author":"Woolfson","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2020.12.019_bib0017","doi-asserted-by":"crossref","first-page":"E137","DOI":"10.3390\/pharmaceutics11030137","article-title":"Tenofovir hot-melt granulation using Gelucire\u24c7 to develop sustained-release vaginal systems for weekly protection against sexual transmission of HIV","volume":"11","author":"Notario-P\u00e9rez","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actbio.2020.12.019_bib0018","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1016\/S2352-3018(19)30145-6","article-title":"Tenofovir disoproxil fumarate intravaginal ring for HIV pre-exposure prophylaxis in sexually active women: a phase 1, single-blind, randomised, controlled trial","volume":"6","author":"Keller","year":"2019","journal-title":"Lancet HIV"},{"key":"10.1016\/j.actbio.2020.12.019_bib0019","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3390\/pharmaceutics12010001","article-title":"Rational design of a multipurpose bioadhesive vaginal film for co-delivery of dapivirine and levonorgestrel","volume":"12","author":"Li","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actbio.2020.12.019_bib0020","article-title":"Preferences and acceptability of vaginal delivery forms for HIV prevention among women, male partners and key informants in South Africa and Zimbabwe: qualitative findings","author":"Musara","year":"2020","journal-title":"AIDS Behav."},{"key":"10.1016\/j.actbio.2020.12.019_bib0021","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11904-019-00450-9","article-title":"Current and future PrEP medications and modalities: on-demand, injectables, and topicals","volume":"16","author":"Beymer","year":"2019","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.actbio.2020.12.019_bib0022","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2164\/jandrol.04104","article-title":"A review of the physical and chemical properties of human semen and the formulation of a semen simulant","volume":"16","author":"Owen","year":"2005","journal-title":"J. Androl."},{"key":"10.1016\/j.actbio.2020.12.019_bib0023","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/jps.20752","article-title":"Temperature and pH sensitive hydrogels: an approach towards smart semen-triggered vaginal microbicidal vehicles","volume":"96","author":"Gupta","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2020.12.019_bib0024","doi-asserted-by":"crossref","first-page":"8343","DOI":"10.1016\/j.biomaterials.2011.05.001","article-title":"Inhibition of the transport of HIV in vitro using a pH-responsive synthetic mucin-like polymer system","volume":"32","author":"Mahalingam","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2020.12.019_bib0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2011.04.004","article-title":"Enzymatic triggered release of an HIV-1 entry inhibitor from prostate specific antigen degradable microparticles","volume":"413","author":"Clark","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2020.12.019_bib0026","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejpb.2011.06.007","article-title":"pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission","volume":"79","author":"Zhang","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2020.12.019_bib0027","doi-asserted-by":"crossref","first-page":"E232","DOI":"10.3390\/pharmaceutics11050232","article-title":"Smart freeze-dried Bigels for the prevention of the sexual transmission of HIV by accelerating the vaginal release of tenofovir during intercourse","volume":"11","author":"Mart\u00edn-Illana","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actbio.2020.12.019_bib0028","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.antiviral.2010.09.010","article-title":"Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets","volume":"88","author":"Garg","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.actbio.2020.12.019_bib0029","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s13346-017-0385-4","article-title":"On-demand microbicide products: design matters","volume":"7","author":"Patel","year":"2017","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.actbio.2020.12.019_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118643","article-title":"Development of mucoadhesive vaginal films based on HPMC and zein as novel formulations to prevent sexual transmission of HIV","volume":"570","author":"Notario-P\u00e9rez","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2020.12.019_bib0031","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/QAI.0000000000000897","article-title":"A phase 1 trial to assess the safety, acceptability, pharmacokinetics, and pharmacodynamics of a novel dapivirine vaginal film","volume":"71","author":"Bunge","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.actbio.2020.12.019_bib0032","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2017.02.021","article-title":"Revisiting structure-property relationship of pH-responsive polymers for drug delivery applications","volume":"253","author":"Bazban-Shotorbani","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2020.12.019_bib0033","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1517\/17425247.2013.736962","article-title":"Eudragit: a technology evaluation","volume":"10","author":"Thakral","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.actbio.2020.12.019_bib0034","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1021\/acs.biomac.0c00249","article-title":"Development and in vitro\/ex vivo characterization of vaginal mucoadhesive bilayer films based on ethylcellulose and biopolymers for vaginal sustained release of tenofovir","volume":"21","author":"Cazorla-Luna","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2020.12.019_bib0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.carbpol.2017.10.001","article-title":"Optimization of tenofovir release from mucoadhesive vaginal tablets by polymer combination to prevent sexual transmission of HIV","volume":"179","author":"Notario-P\u00e9rez","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.actbio.2020.12.019_bib0036","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"Owen","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.actbio.2020.12.019_bib0037","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2020.12.019_bib0038","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1208\/s12249-012-9829-9","article-title":"Matrix tablets: the effect of hydroxypropyl methylcellulose\/anhydrous dibasic calcium phosphate ratio on the release rate of a water-soluble drug through the gastrointestinal tract I. In vitro tests","volume":"13","author":"Mamani","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.actbio.2020.12.019_bib0039","first-page":"97","article-title":"Kinetics and mechanisms of drug release from swellable and non swellable matrices: a review","volume":"4","author":"Chime","year":"2013","journal-title":"Res. J. Pharm. Biol. Chem. Sci."},{"key":"10.1016\/j.actbio.2020.12.019_bib0040","first-page":"64","article-title":"Mathematical comparison of curves with an emphasis on in vitro dissolution profiles","volume":"20","author":"Moore","year":"1996","journal-title":"Pharm. Technol."},{"key":"10.1016\/j.actbio.2020.12.019_bib0041","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.3390\/molecules14114370","article-title":"Characterization and dissolution study of chitosan freeze-dried systems for drug controlled release","volume":"14","author":"Ruiz-Caro","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.actbio.2020.12.019_bib0042","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/pharmaceutics11090485","article-title":"Rational development of liposomal hydrogels: a strategy for topical vaginal antiretroviral drug delivery in the context of HIV prevention","volume":"11","author":"Faria","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actbio.2020.12.019_bib0043","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1007\/s11095-015-1678-2","article-title":"Vaginal microbicide film combinations of two reverse transcriptase inhibitors, EFdA and CSIC, for the prevention of HIV-1 sexual transmission","volume":"32","author":"Zhang","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2020.12.019_bib0044","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.actbio.2016.08.018","article-title":"Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system","volume":"44","author":"Machado","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2020.12.019_bib0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejpb.2018.02.001","article-title":"Composite films for vaginal delivery of tenofovir disoproxil fumarate and emtricitabine","volume":"138","author":"Cautela","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2020.12.019_bib0046","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3389\/fbioe.2019.00390","article-title":"Polymeric electrospun fibrous dressings for topical co-delivery of acyclovir and omega-3 fatty acids","volume":"7","author":"Costa","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.actbio.2020.12.019_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6960-9_1","article-title":"Basic colorimetric proliferation assays: MTT, WST, and resazurin","volume":"1601","author":"Prabst","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.actbio.2020.12.019_bib0048","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1021\/mp4002365","article-title":"In vitro and ex vivo evaluation of polymeric nanoparticles for vaginal and rectal delivery of the anti-HIV drug dapivirine","volume":"10","author":"das Neves","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2020.12.019_bib0049","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.actbio.2015.02.007","article-title":"Precise engineering of dapivirine-loaded nanoparticles for the development of anti-HIV vaginal microbicides","volume":"18","author":"das Neves","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2020.12.019_bib0050","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jnoncrysol.2010.12.031","article-title":"Effects of calcium salts on thermal characteristics of hydroxypropyl methylcellulose films","volume":"357","author":"Sakata","year":"2011","journal-title":"J. Non-Cryst. Solids"},{"key":"10.1016\/j.actbio.2020.12.019_bib0051","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2018.12.011","article-title":"Chitosan-hydroxypropyl methylcellulose tioconazole films: a promising alternative dosage form for the treatment of vaginal candidiasis","volume":"556","author":"Calvo","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2020.12.019_bib0052","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.colsurfb.2016.05.014","article-title":"Composite bi-layered erodible films for potential ocular drug delivery","volume":"145","author":"Boateng","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.actbio.2020.12.019_bib0053","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/md18010044","article-title":"Vaginal polyelectrolyte layer-by-layer films based on chitosan derivatives and Eudragit\u24c7 S100 for pH responsive release of tenofovir","volume":"18","author":"Cazorla-Luna","year":"2020","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.actbio.2020.12.019_bib0054","first-page":"145","article-title":"Investigation of in vitro release kinetics of carbamazepine from Eudragit\u24c7 RS PO and RL PO matrix tablets","volume":"8","author":"Sarker Apu","year":"2009","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.actbio.2020.12.019_bib0055","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1081\/PDT-120024686","article-title":"Studies in preparation and evaluation of pH-independent sustained-release matrix tablets of verapamil HCl using directly compressible Eudragits","volume":"8","author":"Gohel","year":"2003","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.actbio.2020.12.019_bib0056","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2014.12.005","article-title":"Preclinical assessments of vaginal microbicide candidate safety and efficacy","volume":"92","author":"Fern\u00e1ndez-Romero","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2020.12.019_bib0057","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1128\/AAC.00456-10","article-title":"In vitro evaluation of viability, integrity and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides","volume":"54","author":"Gali","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actbio.2020.12.019_bib0058","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmech.2014.03.051","article-title":"PMPA and PMEA prodrugs for the treatment of HIV infections and human papillomavirus (HPV) associated neoplasia and cancer","volume":"6","author":"Pertusati","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actbio.2020.12.019_bib0059","doi-asserted-by":"crossref","first-page":"19541","DOI":"10.1002\/jcb.29262","article-title":"Effect of oleic acid on induction of steatosis and cytotoxicity in BRL 3A cells","volume":"120","author":"Zhang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.actbio.2020.12.019_bib0060","doi-asserted-by":"crossref","first-page":"e48328","DOI":"10.1371\/journal.pone.0048328","article-title":"Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity","volume":"7","author":"Dezzutti","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actbio.2020.12.019_bib0061","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3390\/pharmaceutics6030530","article-title":"Characterization of commercially available vaginal lubricants: a safety perspective","volume":"6","author":"Cunha","year":"2014","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actbio.2020.12.019_bib0062","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijpharm.2014.08.054","article-title":"Development and characterization of a solid dispersion film for the vaginal application of the anti-HIV microbicide UAMC01398","volume":"475","author":"Grammen","year":"2014","journal-title":"Int. J. Pharm."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706120307339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706120307339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:37:51Z","timestamp":1777621071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706120307339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":62,"alternative-id":["S1742706120307339"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2020.12.019","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of pH-sensitive vaginal films based on methacrylate copolymers for topical HIV-1 pre-exposure prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2020.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}